Although controversial, several studies have correlated trinucleotide polymorphisms in SK3 with schizophrenia and migraine [80,81], and changes in SK3 expression with sleep apnoea, sudden infant death syndrome, mood disorders, epilepsy and schizophrenia [24,26,46,82]. This evidence concerns the gene KCNN3 and epilepsy.